Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen.
Proskurina AS, Gvozdeva TS, Potter EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OY, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Uchakin PN, Rogachev VA, Shurdov MA, Bogachev SS.
Proskurina AS, et al. Among authors: ryabicheva tg.
BMC Cancer. 2016 Aug 18;16:651. doi: 10.1186/s12885-016-2711-5.
BMC Cancer. 2016.
PMID: 27538465
Free PMC article.
Clinical Trial.